Japan Sends New Flu Virus Strains To Four Flu Vaccine Makers
This article was originally published in PharmAsia News
Executive SummaryJapan National Infectious Disease Institute sent two H1N1 flu virus strains to four Japanese flu vaccine makers. The Ministry of Health, Labor and Welfare disclosed that the two strains were from Australia's Commonwealth Serum Laboratories and New York Medical College. The target production for the new flu vaccine is July. The four makers are the Chemo-Sero-Therapeutic Research Institute, Denka Seiken, the Research Foundation for Microbial Disease of Osaka University and Kitazato Institute. (Click here for more - Japanese language
You may also be interested in...
Japan bioventure BioComo was set up around 10 years ago and has since been honing its technology platform. It is now preparing to move into the clinic with a novel vector for immuno-oncology and to raise new funds to support pipeline development.
Several newly repurposed drugs, including a Bayer antimalarial, have shown potential benefits against the new coronavirus, promoting China to add several to its latest revised treatment guidelines.
Oncology Center of Excellence is reviewing a research report on fluorouracil, and will next look to update cisplatin's label, but eventually must convince the reference product sponsor to submit the changes.